Thevenin K, Tieche I, Di Benedetto C, Schrager M, Dye K
Virol J. 2024; 21(1):125.
PMID: 38831469
PMC: 11149282.
DOI: 10.1186/s12985-024-02395-x.
Koma T, Doi N, Le B, Kondo T, Ishizue M, Tokaji C
Viruses. 2023; 15(12).
PMID: 38140666
PMC: 10747208.
DOI: 10.3390/v15122424.
Terzioglu M, Veeroja K, Montonen T, Ihalainen T, Salminen T, Benit P
Elife. 2023; 12.
PMID: 38079477
PMC: 10712956.
DOI: 10.7554/eLife.89232.
Koma T, Doi N, Takemoto M, Watanabe K, Yamamoto H, Nakashima S
Viruses. 2021; 13(10).
PMID: 34696508
PMC: 8537775.
DOI: 10.3390/v13102079.
Koma T, Yokoyama M, Kotani O, Doi N, Nakanishi N, Okubo H
J Virol. 2021; 95(13):e0217720.
PMID: 33883222
PMC: 8315996.
DOI: 10.1128/JVI.02177-20.
Association Between Simian Virus 40 and Human Tumors.
Rotondo J, Mazzoni E, Bononi I, Tognon M, Martini F
Front Oncol. 2019; 9:670.
PMID: 31403031
PMC: 6669359.
DOI: 10.3389/fonc.2019.00670.
Concomitant Enhancement of HIV-1 Replication Potential and Neutralization-Resistance in Concert With Three Adaptive Mutations in Env V1/C2/C4 Domains.
Doi N, Yokoyama M, Koma T, Kotani O, Sato H, Adachi A
Front Microbiol. 2019; 10:2.
PMID: 30705669
PMC: 6344430.
DOI: 10.3389/fmicb.2019.00002.
Production of HIV-1 mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region.
Nomaguchi M, Doi N, Yoshida T, Koma T, Adachi S, Ode H
Front Microbiol. 2018; 8:2542.
PMID: 29326677
PMC: 5741601.
DOI: 10.3389/fmicb.2017.02542.
Introduction of H2C2-type zinc-binding residues into HIV-2 Vpr increases its expression level.
Koga R, Yamamoto M, Ciftci H, Otsuka M, Fujita M
FEBS Open Bio. 2018; 8(1):146-153.
PMID: 29321964
PMC: 5757179.
DOI: 10.1002/2211-5463.12358.
Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.
Nomaguchi M, Doi N, Sakai Y, Ode H, Iwatani Y, Ueno T
J Virol. 2016; 90(9):4563-4578.
PMID: 26912631
PMC: 4836328.
DOI: 10.1128/JVI.02939-15.
In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells.
Yokoyama M, Nomaguchi M, Doi N, Kanda T, Adachi A, Sato H
Front Microbiol. 2016; 7:110.
PMID: 26903989
PMC: 4746247.
DOI: 10.3389/fmicb.2016.00110.
Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A, Welch R, Zhao B, Ta T, Keles S, Johannsen E
J Virol. 2016; 90(6):2906-19.
PMID: 26719268
PMC: 4810642.
DOI: 10.1128/JVI.02737-15.
The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.
Ohashi M, Holthaus A, Calderwood M, Lai C, Krastins B, Sarracino D
PLoS Pathog. 2015; 11(4):e1004822.
PMID: 25855980
PMC: 4391933.
DOI: 10.1371/journal.ppat.1004822.
Role of poly-proline motif in HIV-2 Vpx expression.
Miyake A, Miyazaki Y, Fujita M, Nomaguchi M, Adachi A
Front Microbiol. 2014; 5:24.
PMID: 24478770
PMC: 3904113.
DOI: 10.3389/fmicb.2014.00024.
Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors.
Nomaguchi M, Yokoyama M, Kono K, Nakayama E, Shioda T, Doi N
J Virol. 2013; 87(21):11447-61.
PMID: 23966385
PMC: 3807366.
DOI: 10.1128/JVI.01549-13.
Site-Directed Mutagenesis of HIV-1 vpu Gene Demonstrates Two Clusters of Replication-Defective Mutants with Distinct Ability to Down-Modulate Cell Surface CD4 and Tetherin.
Nomaguchi M, Doi N, Fujiwara S, Fujita M, Adachi A
Front Microbiol. 2011; 1:116.
PMID: 21607084
PMC: 3095391.
DOI: 10.3389/fmicb.2010.00116.
The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
Meng Q, Hagemeier S, Fingeroth J, Gershburg E, Pagano J, Kenney S
J Virol. 2010; 84(9):4534-42.
PMID: 20181711
PMC: 2863746.
DOI: 10.1128/JVI.02487-09.
Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.
Meng Q, Hagemeier S, Kuny C, Kalejta R, Kenney S
J Virol. 2010; 84(9):4524-33.
PMID: 20147387
PMC: 2863785.
DOI: 10.1128/JVI.02456-09.
Development of a generic transient transfection process at 100 L scale.
Tuvesson O, Uhe C, Rozkov A, Lullau E
Cytotechnology. 2008; 56(2):123-36.
PMID: 19002850
PMC: 2259262.
DOI: 10.1007/s10616-008-9135-2.
Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages.
Fujita M, Otsuka M, Miyoshi M, Khamsri B, Nomaguchi M, Adachi A
J Virol. 2008; 82(15):7752-6.
PMID: 18495778
PMC: 2493314.
DOI: 10.1128/JVI.01003-07.